Page 37 - நேரம் டேவிஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Veeva Systems: First Patient Completes Digital Consent with Veeva Clinical Network in Phase 2b Study Milestone accelerates industry s move toward paperless, patient-centric trials Veeva Systems (NYSE: VEEV) today announced that Veeva eConsent, a MyVeeva for Patients application built on Veeva Clinical Network, had its first patient complete an electronic consent for an early phase clinical trial by Crofoot Research Center. Veeva eConsent is the first validated application for sites and patients that transforms the consent process from manual and paper-based to an end-to-end digital experience. Patients can review documents and protocols and provide consent via mobile phone, streamlining the experience for both patients and sites.

Charles sydnorTim davisDeivis mercadoCrofoot research centerVeeva systems incA public benefit corporationVeeva clinical networkCrofoot researchPublic benefit corporationFinancial conditionVeeva systemsசார்லஸ் சிட்னர்நேரம் டேவிஸ்சிரோபோவ்ட் ஆராய்ச்சி மையம்சிரோபோவ்ட் ஆராய்ச்சிபொது நன்மை நிறுவனம்